A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. As reported Monday (Sept. 4 ...

Researchers at Purdue University have developed a new type of cancer therapy that uses a modified microRNA, miR-34a, to block cancer cell division. In preclinical tests in mice, treatment using the ...

COLUMBUS, Ohio, April 02, 2026--(BUSINESS WIRE)--Armatus Bio, a late-preclinical stage biotech innovator developing vectorized RNAi medicines in neuromuscular disorders, today announced the ...

A new cancer therapy attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. A new cancer therapy developed by Purdue University researchers ...

A new therapy for cancer uses microRNA to slow or stop division of cancer cells. (Photo provided by Second Bay Studios) WEST LAFAYETTE, Ind. – A new cancer therapy developed by Purdue University ...

WEST LAFAYETTE, Ind. – A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. As ...

To explore the pan-cancer expression pattern of miR-668-3p, we retrieved the TCGA (Pan-Cancer) dataset from the UCSC Xena database (https://xenabrowser.net ...

Armatus Bio, a late-preclinical stage biotech innovator developing vectorized RNAi medicines in neuromuscular disorders, today announced the publication of foundational data in Molecular Therapy ...

Research published in Molecular Therapy Nucleic Acids demonstrates broad biodistribution and controlled PMP22 silencing, supporting advancement toward human trials Armatus Bio, a late-preclinical ...